X-101349900-C-T

Variant summary

Our verdict is Likely benign. Variant got -5 ACMG points: 3P and 8B. PM1PP2BP4_ModerateBP6_ModerateBS2

The NM_000061.3(BTK):​c.1965G>A​(p.Met655Ile) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00000182 in 1,095,952 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 2 hemizygotes in GnomAD. In-silico tool predicts a benign outcome for this variant. 13/20 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).

Frequency

Genomes: not found (cov: 22)
Exomes 𝑓: 0.0000018 ( 0 hom. 2 hem. )

Consequence

BTK
NM_000061.3 missense

Scores

1
4
12

Clinical Significance

Likely benign criteria provided, single submitter B:1

Conservation

PhyloP100: 1.22
Variant links:
Genes affected
BTK (HGNC:1133): (Bruton tyrosine kinase) The protein encoded by this gene plays a crucial role in B-cell development. Mutations in this gene cause X-linked agammaglobulinemia type 1, which is an immunodeficiency characterized by the failure to produce mature B lymphocytes, and associated with a failure of Ig heavy chain rearrangement. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Dec 2013]

Genome browser will be placed here

ACMG classification

Classification made for transcript

Verdict is Likely_benign. Variant got -5 ACMG points.

PM1
In a domain Protein kinase (size 253) in uniprot entity BTK_HUMAN there are 43 pathogenic changes around while only 1 benign (98%) in NM_000061.3
PP2
Missense variant in the BTK gene, where missense mutations are typically associated with disease (based on misZ statistic). The gene has 90 curated pathogenic missense variants (we use a threshold of 10). The gene has 26 curated benign missense variants. Gene score misZ: 4.0394 (above the threshold of 3.09). GenCC associations: The gene is linked to short stature due to isolated growth hormone deficiency with X-linked hypogammaglobulinemia, Bruton-type agammaglobulinemia, isolated growth hormone deficiency type III.
BP4
Computational evidence support a benign effect (MetaRNN=0.15746889).
BP6
Variant X-101349900-C-T is Benign according to our data. Variant chrX-101349900-C-T is described in ClinVar as [Likely_benign]. Clinvar id is 3636307.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Hemizygotes in GnomAdExome4 at 2 XL gene

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
BTKNM_000061.3 linkc.1965G>A p.Met655Ile missense_variant Exon 19 of 19 ENST00000308731.8 NP_000052.1 Q06187-1Q5JY90
BTKNM_001287344.2 linkc.2067G>A p.Met689Ile missense_variant Exon 19 of 19 NP_001274273.1 Q06187-2
BTKNM_001287345.2 linkc.1437G>A p.Met479Ile missense_variant Exon 17 of 17 NP_001274274.1 Q06187Q5JY90

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
BTKENST00000308731.8 linkc.1965G>A p.Met655Ile missense_variant Exon 19 of 19 1 NM_000061.3 ENSP00000308176.8 Q06187-1

Frequencies

GnomAD3 genomes
Cov.:
22
GnomAD3 exomes
AF:
0.0000109
AC:
2
AN:
183449
Hom.:
0
AF XY:
0.0000295
AC XY:
2
AN XY:
67879
show subpopulations
Gnomad AFR exome
AF:
0.00
Gnomad AMR exome
AF:
0.00
Gnomad ASJ exome
AF:
0.00
Gnomad EAS exome
AF:
0.00
Gnomad SAS exome
AF:
0.000105
Gnomad FIN exome
AF:
0.00
Gnomad NFE exome
AF:
0.00
Gnomad OTH exome
AF:
0.00
GnomAD4 exome
AF:
0.00000182
AC:
2
AN:
1095952
Hom.:
0
Cov.:
29
AF XY:
0.00000553
AC XY:
2
AN XY:
361382
show subpopulations
Gnomad4 AFR exome
AF:
0.00
Gnomad4 AMR exome
AF:
0.00
Gnomad4 ASJ exome
AF:
0.00
Gnomad4 EAS exome
AF:
0.00
Gnomad4 SAS exome
AF:
0.0000370
Gnomad4 FIN exome
AF:
0.00
Gnomad4 NFE exome
AF:
0.00
Gnomad4 OTH exome
AF:
0.00
GnomAD4 genome
Cov.:
22
Bravo
AF:
0.00000756
ExAC
AF:
0.0000165
AC:
2

ClinVar

Significance: Likely benign
Submissions summary: Benign:1
Revision: criteria provided, single submitter
LINK: link

Submissions by phenotype

X-linked agammaglobulinemia with growth hormone deficiency Benign:1
Mar 12, 2024
Labcorp Genetics (formerly Invitae), Labcorp
Significance: Likely benign
Review Status: criteria provided, single submitter
Collection Method: clinical testing

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.16
BayesDel_addAF
Benign
-0.13
T
BayesDel_noAF
Benign
-0.22
CADD
Benign
22
DANN
Uncertain
0.99
DEOGEN2
Benign
0.41
.;.;T
FATHMM_MKL
Uncertain
0.92
D
LIST_S2
Uncertain
0.88
D;D;D
M_CAP
Benign
0.029
D
MetaRNN
Benign
0.16
T;T;T
MetaSVM
Benign
-0.65
T
MutationAssessor
Benign
0.57
.;.;N
PrimateAI
Uncertain
0.58
T
PROVEAN
Benign
-0.93
N;.;N
REVEL
Benign
0.20
Sift
Pathogenic
0.0
D;.;T
Sift4G
Benign
0.44
T;T;T
Polyphen
0.011
B;.;B
Vest4
0.21
MutPred
0.26
.;.;Loss of loop (P = 0.1242);
MVP
0.90
MPC
1.4
ClinPred
0.28
T
GERP RS
5.1
RBP_binding_hub_radar
0.0
RBP_regulation_power_radar
1.7
Varity_R
0.43
gMVP
0.83

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs782709592; hg19: chrX-100604888; API